nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—Dissociation—Varenicline—nicotine dependence	0.126	0.32	CcSEcCtD
Methysergide—Mydriasis—Varenicline—nicotine dependence	0.0229	0.0582	CcSEcCtD
Methysergide—Urine output increased—Varenicline—nicotine dependence	0.0165	0.042	CcSEcCtD
Methysergide—Euphoric mood—Varenicline—nicotine dependence	0.0157	0.0399	CcSEcCtD
Methysergide—Polyuria—Varenicline—nicotine dependence	0.0151	0.0384	CcSEcCtD
Methysergide—HTR1F—brain—nicotine dependence	0.0135	0.0753	CbGeAlD
Methysergide—HTR1E—brain—nicotine dependence	0.0117	0.0652	CbGeAlD
Methysergide—HTR1B—cardiovascular system—nicotine dependence	0.0113	0.0629	CbGeAlD
Methysergide—HTR1D—cardiovascular system—nicotine dependence	0.0109	0.0609	CbGeAlD
Methysergide—Weight increased—Varenicline—nicotine dependence	0.0104	0.0265	CcSEcCtD
Methysergide—HTR2B—cardiovascular system—nicotine dependence	0.0102	0.0566	CbGeAlD
Methysergide—HTR6—brain—nicotine dependence	0.00919	0.0512	CbGeAlD
Methysergide—HTR1A—cardiovascular system—nicotine dependence	0.00911	0.0507	CbGeAlD
Methysergide—Oedema peripheral—Varenicline—nicotine dependence	0.00904	0.023	CcSEcCtD
Methysergide—HTR1B—midbrain—nicotine dependence	0.00882	0.0491	CbGeAlD
Methysergide—HTR7—cardiovascular system—nicotine dependence	0.00871	0.0485	CbGeAlD
Methysergide—HTR1D—midbrain—nicotine dependence	0.00854	0.0475	CbGeAlD
Methysergide—HTR2C—midbrain—nicotine dependence	0.00845	0.0471	CbGeAlD
Methysergide—Lisuride—DRD2—nicotine dependence	0.00808	0.346	CrCbGaD
Methysergide—SIGMAR1—midbrain—nicotine dependence	0.00796	0.0443	CbGeAlD
Methysergide—Ergotamine—DRD2—nicotine dependence	0.00776	0.333	CrCbGaD
Methysergide—Back pain—Varenicline—nicotine dependence	0.00773	0.0196	CcSEcCtD
Methysergide—Bromocriptine—DRD2—nicotine dependence	0.00749	0.321	CrCbGaD
Methysergide—Ill-defined disorder—Varenicline—nicotine dependence	0.00741	0.0188	CcSEcCtD
Methysergide—Malaise—Varenicline—nicotine dependence	0.0072	0.0183	CcSEcCtD
Methysergide—HTR1A—midbrain—nicotine dependence	0.00712	0.0396	CbGeAlD
Methysergide—Convulsion—Varenicline—nicotine dependence	0.00692	0.0176	CcSEcCtD
Methysergide—Chest pain—Varenicline—nicotine dependence	0.0068	0.0173	CcSEcCtD
Methysergide—Arthralgia—Varenicline—nicotine dependence	0.0068	0.0173	CcSEcCtD
Methysergide—Myalgia—Varenicline—nicotine dependence	0.0068	0.0173	CcSEcCtD
Methysergide—HTR7—midbrain—nicotine dependence	0.0068	0.0379	CbGeAlD
Methysergide—Discomfort—Varenicline—nicotine dependence	0.00672	0.0171	CcSEcCtD
Methysergide—Oedema—Varenicline—nicotine dependence	0.00652	0.0166	CcSEcCtD
Methysergide—Thrombocytopenia—Varenicline—nicotine dependence	0.00638	0.0162	CcSEcCtD
Methysergide—Tachycardia—Varenicline—nicotine dependence	0.00636	0.0162	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00594	0.0151	CcSEcCtD
Methysergide—Insomnia—Varenicline—nicotine dependence	0.0059	0.015	CcSEcCtD
Methysergide—Dyspnoea—Varenicline—nicotine dependence	0.00581	0.0148	CcSEcCtD
Methysergide—Somnolence—Varenicline—nicotine dependence	0.0058	0.0147	CcSEcCtD
Methysergide—Dyspepsia—Varenicline—nicotine dependence	0.00574	0.0146	CcSEcCtD
Methysergide—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00564	0.014	CbGpPWpGaD
Methysergide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00563	0.0143	CcSEcCtD
Methysergide—Fatigue—Varenicline—nicotine dependence	0.00562	0.0143	CcSEcCtD
Methysergide—Pain—Varenicline—nicotine dependence	0.00557	0.0142	CcSEcCtD
Methysergide—Constipation—Varenicline—nicotine dependence	0.00557	0.0142	CcSEcCtD
Methysergide—HTR1B—brain—nicotine dependence	0.00554	0.0308	CbGeAlD
Methysergide—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00553	0.0137	CbGpPWpGaD
Methysergide—HTR2A—cardiovascular system—nicotine dependence	0.00543	0.0302	CbGeAlD
Methysergide—Feeling abnormal—Varenicline—nicotine dependence	0.00537	0.0136	CcSEcCtD
Methysergide—HTR1D—brain—nicotine dependence	0.00536	0.0299	CbGeAlD
Methysergide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00533	0.0135	CcSEcCtD
Methysergide—HTR2C—brain—nicotine dependence	0.00531	0.0296	CbGeAlD
Methysergide—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00519	0.0129	CbGpPWpGaD
Methysergide—Abdominal pain—Varenicline—nicotine dependence	0.00515	0.0131	CcSEcCtD
Methysergide—Body temperature increased—Varenicline—nicotine dependence	0.00515	0.0131	CcSEcCtD
Methysergide—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00501	0.0124	CbGpPWpGaD
Methysergide—SIGMAR1—brain—nicotine dependence	0.005	0.0278	CbGeAlD
Methysergide—HTR2B—brain—nicotine dependence	0.00499	0.0278	CbGeAlD
Methysergide—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00498	0.0123	CbGpPWpGaD
Methysergide—Asthenia—Varenicline—nicotine dependence	0.00468	0.0119	CcSEcCtD
Methysergide—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00458	0.0114	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00449	0.0111	CbGpPWpGaD
Methysergide—HTR1A—brain—nicotine dependence	0.00447	0.0249	CbGeAlD
Methysergide—Diarrhoea—Varenicline—nicotine dependence	0.00446	0.0113	CcSEcCtD
Methysergide—HTR1F—GPCR ligand binding—TAS2R16—nicotine dependence	0.00434	0.0107	CbGpPWpGaD
Methysergide—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00433	0.0107	CbGpPWpGaD
Methysergide—Dizziness—Varenicline—nicotine dependence	0.00431	0.011	CcSEcCtD
Methysergide—HTR7—brain—nicotine dependence	0.00427	0.0238	CbGeAlD
Methysergide—HTR2A—midbrain—nicotine dependence	0.00424	0.0236	CbGeAlD
Methysergide—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00421	0.0104	CbGpPWpGaD
Methysergide—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00419	0.0104	CbGpPWpGaD
Methysergide—Vomiting—Varenicline—nicotine dependence	0.00414	0.0105	CcSEcCtD
Methysergide—Rash—Varenicline—nicotine dependence	0.00411	0.0104	CcSEcCtD
Methysergide—Dermatitis—Varenicline—nicotine dependence	0.00411	0.0104	CcSEcCtD
Methysergide—HTR1E—GPCR ligand binding—TAS2R16—nicotine dependence	0.00409	0.0101	CbGpPWpGaD
Methysergide—Nausea—Varenicline—nicotine dependence	0.00387	0.00984	CcSEcCtD
Methysergide—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00364	0.00901	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00342	0.00847	CbGpPWpGaD
Methysergide—HTR1F—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00302	0.00748	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00293	0.00726	CbGpPWpGaD
Methysergide—HTR1E—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00285	0.00706	CbGpPWpGaD
Methysergide—HTR1F—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0028	0.00695	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—TAS2R16—nicotine dependence	0.00279	0.00693	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—TAS2R16—nicotine dependence	0.00279	0.00692	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00277	0.00687	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00272	0.00673	CbGpPWpGaD
Methysergide—HTR2A—brain—nicotine dependence	0.00266	0.0148	CbGeAlD
Methysergide—HTR1E—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00264	0.00655	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00255	0.00632	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00253	0.00627	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00245	0.00608	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0024	0.00595	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00231	0.00573	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00227	0.00561	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—TAS2R16—nicotine dependence	0.00223	0.00552	CbGpPWpGaD
Methysergide—HTR1F—G alpha (i) signalling events—DRD2—nicotine dependence	0.00218	0.00541	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00215	0.00534	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—TAS2R16—nicotine dependence	0.0021	0.0052	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00207	0.00513	CbGpPWpGaD
Methysergide—HTR1E—G alpha (i) signalling events—DRD2—nicotine dependence	0.00206	0.0051	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00206	0.0051	CbGpPWpGaD
Methysergide—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00203	0.00502	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00195	0.00485	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00193	0.00479	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—FGD1—nicotine dependence	0.00192	0.00477	CbGpPWpGaD
Methysergide—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00191	0.00474	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00189	0.00469	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—OPRM1—nicotine dependence	0.00183	0.00453	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—FGD1—nicotine dependence	0.00181	0.0045	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00181	0.00448	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0018	0.00447	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00179	0.00444	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00179	0.00443	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00178	0.0044	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00175	0.00435	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—FGD1—nicotine dependence	0.00175	0.00433	CbGpPWpGaD
Methysergide—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00174	0.0043	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—OPRM1—nicotine dependence	0.00172	0.00427	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00169	0.00419	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00165	0.00409	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—FGD1—nicotine dependence	0.00165	0.00408	CbGpPWpGaD
Methysergide—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00164	0.00406	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—DRD2—nicotine dependence	0.00159	0.00395	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00158	0.00391	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00158	0.00391	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00157	0.00388	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00155	0.00383	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00155	0.00383	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00154	0.00381	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00153	0.0038	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00153	0.0038	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0015	0.00373	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00144	0.00357	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00144	0.00357	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TAS2R16—nicotine dependence	0.00143	0.00355	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TAS2R16—nicotine dependence	0.00143	0.00355	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00142	0.00353	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00141	0.0035	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.0014	0.00346	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00139	0.00345	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00137	0.00339	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00134	0.00331	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00133	0.0033	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—DRD2—nicotine dependence	0.00132	0.00328	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TAS2R16—nicotine dependence	0.00131	0.00326	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00131	0.00324	CbGpPWpGaD
Methysergide—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00131	0.00324	CbGpPWpGaD
Methysergide—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0013	0.00323	CbGpPWpGaD
Methysergide—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0013	0.00321	CbGpPWpGaD
Methysergide—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00127	0.00314	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—DRD2—nicotine dependence	0.00125	0.00309	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TAS2R16—nicotine dependence	0.00124	0.00307	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.00124	0.00307	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—FGD1—nicotine dependence	0.00124	0.00307	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00123	0.00305	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.0012	0.00298	CbGpPWpGaD
Methysergide—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00119	0.00295	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.00118	0.00292	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—OPRM1—nicotine dependence	0.00118	0.00292	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00117	0.0029	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00117	0.0029	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00116	0.00288	CbGpPWpGaD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00115	0.00286	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00115	0.00284	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00114	0.00284	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00114	0.00282	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00113	0.0028	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.00113	0.00279	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—FGD1—nicotine dependence	0.00112	0.00279	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00112	0.00277	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00112	0.00277	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.00112	0.00277	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00111	0.00275	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.00109	0.00271	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00109	0.00269	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00108	0.00267	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00106	0.00263	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00106	0.00262	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00104	0.00258	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.00103	0.00256	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.00103	0.00256	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.00103	0.00255	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00102	0.00253	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00101	0.0025	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000989	0.00245	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—OPRM1—nicotine dependence	0.000975	0.00242	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—FGD1—nicotine dependence	0.000973	0.00241	CbGpPWpGaD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000966	0.0024	CbGpPWpGaD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000962	0.00238	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.000938	0.00233	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000917	0.00227	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000917	0.00227	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000913	0.00226	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.000911	0.00226	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—OPRM1—nicotine dependence	0.000885	0.00219	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000872	0.00216	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000868	0.00215	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKR1B10—nicotine dependence	0.00086	0.00213	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000852	0.00211	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000851	0.00211	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000847	0.0021	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000846	0.0021	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000845	0.0021	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000841	0.00208	CbGpPWpGaD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000835	0.00207	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000833	0.00206	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000829	0.00205	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000828	0.00205	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000828	0.00205	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000824	0.00204	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000823	0.00204	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000793	0.00196	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000778	0.00193	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000773	0.00192	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000753	0.00187	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.000747	0.00185	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00072	0.00178	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000715	0.00177	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—DRD2—nicotine dependence	0.000705	0.00175	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.000678	0.00168	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000666	0.00165	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	0.000665	0.00165	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000665	0.00165	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FGD1—nicotine dependence	0.000664	0.00165	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000661	0.00164	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.00066	0.00164	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000647	0.0016	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.000646	0.0016	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.000642	0.00159	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—DRD2—nicotine dependence	0.00064	0.00159	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000631	0.00156	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000627	0.00155	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000627	0.00155	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000624	0.00155	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.000616	0.00153	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000608	0.00151	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000607	0.0015	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—WASF2—nicotine dependence	0.000606	0.0015	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000605	0.0015	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	0.000604	0.0015	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.0006	0.00149	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000588	0.00146	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000587	0.00146	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	0.000587	0.00145	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000583	0.00144	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—WASF1—nicotine dependence	0.000581	0.00144	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000571	0.00141	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.000554	0.00137	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000552	0.00137	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000545	0.00135	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000542	0.00134	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000536	0.00133	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	0.000523	0.0013	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000493	0.00122	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000492	0.00122	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.00049	0.00122	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.00049	0.00121	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	0.000481	0.00119	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	0.000481	0.00119	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000478	0.00118	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000468	0.00116	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000448	0.00111	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000445	0.0011	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000439	0.00109	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD2—nicotine dependence	0.000437	0.00108	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD2—nicotine dependence	0.000437	0.00108	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000435	0.00108	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.000434	0.00108	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000433	0.00107	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000426	0.00106	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000425	0.00105	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.000425	0.00105	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—WASF2—nicotine dependence	0.000414	0.00103	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—WASF2—nicotine dependence	0.000413	0.00102	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.000411	0.00102	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.000402	0.000997	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD2—nicotine dependence	0.000401	0.000993	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.000399	0.000989	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—WASF1—nicotine dependence	0.000397	0.000983	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—WASF1—nicotine dependence	0.000396	0.000982	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.000394	0.000976	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000387	0.000958	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.000385	0.000955	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD2—nicotine dependence	0.000378	0.000937	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—WASF2—nicotine dependence	0.000378	0.000936	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000376	0.000931	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—WASF1—nicotine dependence	0.000362	0.000898	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—OPRM1—nicotine dependence	0.000357	0.000885	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—OPRM1—nicotine dependence	0.000357	0.000884	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000356	0.000883	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000355	0.000879	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.000354	0.000879	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000347	0.00086	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	0.000326	0.000808	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	0.000324	0.000802	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000322	0.000798	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000308	0.000763	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—WASF2—nicotine dependence	0.000306	0.000759	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.000305	0.000755	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—WASF1—nicotine dependence	0.000294	0.000728	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000292	0.000724	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.00028	0.000693	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.000265	0.000656	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	0.000264	0.000655	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.000263	0.000652	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD2—nicotine dependence	0.000258	0.00064	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD2—nicotine dependence	0.000258	0.000639	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000256	0.000635	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000254	0.000629	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000251	0.000622	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD2—nicotine dependence	0.000236	0.000584	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.000228	0.000566	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD2—nicotine dependence	0.000191	0.000474	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.000471	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD2—nicotine dependence	0.000165	0.000409	CbGpPWpGaD
